US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

37.02

+0.08000.22%

Volume:41.12K

Turnover:1.53M

Market Cap:862.94M

PE:- -

High:37.38

Open:36.94

Low:36.94

Close:36.94

52wk High:38.19

52wk Low:28.26

Shares:23.31M

Float Shares:23.31M

Volume Ratio:1.54

T/O Rate:0.18%

Dividend:0.22

Dividend Rate:0.60%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

Addus HomeCare Consolidation Can't Offset Medicaid Funding Pressures, BofA Says

MT Newswires Live

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Cabaletta Bio Boosts Cash Through Warrant Exercises

Scholar Rock price target raised to $84 from $76 at BMO Capital

Long-Term Bribery Involving 30+ Pharmaceutical Firms Prompts Hospital Response

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Hospital Staff in Hebei Province Found Guilty of Accepting Bribes 46 Times Over 11 Years, Totaling 184 Million Yuan

Scholar Rock announces FDA approval of isembyld

Pharming wins FDA nod to extend Joenja use to younger APDS children

MEDCAPTAIN's Hong Kong IPO: A Medical Device Empire Built on Acquisitions Faces Multiple Headwinds

Nextbiomedical Targets Global Investors at 2026 KIS BioTech Day

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

Hongkou Pioneers 'Automatic Benefits' for Veterans' Medical Subsidies, Eliminating Paperwork Trips

Tellgen's Subsidiary Device Registration Application Accepted by Regulator

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

Bank of America Reveals 5.22% Indirect Stake in Qiagen

Revvity to acquire Human Cell Design

Actinogen Medical Expands ASX-Quoted Share Base

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/RSPH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":37.02,"timestamp":1790263860963,"preClose":36.94,"halted":0,"volume":41120,"delay":0,"changeRate":0.0021656740660532053,"floatShares":23310000,"shares":23310000,"eps":0,"marketStatus":"Trading","change":0.08,"latestTime":"09-24 11:31:55 EDT","open":36.94,"high":37.38,"low":36.94,"amount":1530632.1704,"amplitude":0.011911,"askPrice":37.05,"askSize":2600,"bidPrice":36.99,"bidSize":1400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790280000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":36.94,"sharesOutstanding":23410000,"nav":37.17799,"aum":866618946.9,"dividendRate":0.005986,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.94,"preClose":36.94,"latestTime":"08:12 EDT","volume":1,"amount":36.94,"timestamp":1790251942763,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.94,"preClose":36.94,"latestTime":"19:30 EDT","volume":24,"amount":884.66,"timestamp":1790206202530,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.544488,"impliedVol":0.0046,"impliedVolPercentile":0.0359},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23310000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.544488,"shares":23310000,"dividePrice":0.2216,"high":37.38,"amplitude":0.011911,"preClose":36.94,"low":36.94,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":37.02,"committee":-0.3,"eps":0,"divideRate":0.005986,"volume":41120,"delay":0,"ttmEps":0,"open":36.94,"prevYearClose":31.85,"prevWeekClose":36.73,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":36.97,"twentyDayClose":37.84,"sixtyDayClose":33.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"RSPH","amount":0.05159,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.04585,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667869541","title":"Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2667869541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667869541?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:37","pubTimestamp":1789418272,"startTime":"0","endTime":"0","summary":"Niki BioSolutions Inc ( ($NIKI) ) just unveiled an announcement. Niki BioSolutions Inc operates in the biotechnology and molecular diagnostics sect...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","BBP","IBB","IEIH","AGNG","HELX","FHLC","JDOC","RSPH","GNMX","HTEC","BK4585","LNGR","BK4588","XT","SYNB","FWD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664069","title":"Addus HomeCare Consolidation Can't Offset Medicaid Funding Pressures, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664069","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664069?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:59","pubTimestamp":1789397969,"startTime":"0","endTime":"0","summary":"Addus HomeCare's (ADUS) exposure to Medicaid funding pressures is expected to be offset by potential benefits from industry consolidation, although slowing state reimbursement rates could constrain gr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RSPH","IE00BN0W2V16.EUR","BK4196","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","ADUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4585","BK4007","PSCH","IYH","NVIB","TECB","BK4588","RSPH","SYNB","MRNY","LABU","BFRI","LFSC","BMED","MEDI","MRNX","IBB","BBP","IEIH","FRTY","TBXU","GNMX","PINK","XLVX","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","IDNA","MRNY","LFSC","IEIH","TBXU","IYH","SYNB","BMED","MRNX","TECB","IBB","BBP","GNMX","GDOC","NVIB","PINK","XLVX","LABU","PSCH","BK4588","BK4585","RSPH","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666613","title":"Cabaletta Bio Boosts Cash Through Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666613?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:31","pubTimestamp":1789389071,"startTime":"0","endTime":"0","summary":"Cabaletta Bio ( ($CABA) ) has provided an update. Cabaletta Bio, a biotechnology company developing engineered immune cell therapies for autoimmune...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","XT","CABA","FWD","BK4139","BK4585","LNGR","BK4588","BBP","FHLC","JDOC","DARP","IBB","IEIH","SYNB","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","SYNB","SRRK","IBRN","BK4139","PINK","LABU","TECB","XLVX","LFSC","IYH","BBP","RSPH","BK4588","MEDI","IBB","IDNA","TBXU","GDOC","FRTY","NVIB","BK4585","MRNX","GNMX","MRNY","THNR","BMED","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122259450","title":"Long-Term Bribery Involving 30+ Pharmaceutical Firms Prompts Hospital Response","url":"https://stock-news.laohu8.com/highlight/detail?id=1122259450","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122259450?lang=en_us&edition=fundamental","pubTime":"2026-09-14 12:21","pubTimestamp":1789359679,"startTime":"0","endTime":"0","summary":"On September 13, China's National Healthcare Security Administration released a report detailing commercial bribery cases in medical institutions' pharmaceutical procurement. The report revealed that...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","AGNG","HART","BK1574","IEIH","GDOC","LNGR","09996","MEDX","BK1583","MDEV","RSPH","PTH","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4179","BK4588","BK4139","IEIH","TBXU","LABU","GDOC","IDNA","PINK","BMED","MEDI","PSCH","FET","TLX","NVIB","SYNB","IYH","LFSC","RSPH","GNMX","IBB","TECB","BBP","FRTY","MRNX","MRNY","XLVX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173526187","title":"Hospital Staff in Hebei Province Found Guilty of Accepting Bribes 46 Times Over 11 Years, Totaling 184 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1173526187","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173526187?lang=en_us&edition=fundamental","pubTime":"2026-09-13 09:40","pubTimestamp":1789263647,"startTime":"0","endTime":"0","summary":"China's medical insurance regulator, which set up a credit evaluation system for pharmaceutical pricing and procurement in August 2020, has uncovered a significant case of commercial bribery in the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1100","BK1515","MEDX","BK1574","RSPH","BK1161","MDEV","BK1583","GDOC","09939","PTH","HART","LGHT","AGNG","IEIH","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BMED","IYH","XLVX","LABU","PSCH","MRNY","IBRN","MRNX","TBXU","MEDI","BK4139","SRRK","THNR","GNMX","BBP","NVIB","IBB","IDNA","BK4585","FRTY","PINK","TECB","BK4588","IEIH","SYNB","GDOC","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","IYH","SYNB","IEIH","PINK","TBXU","LFSC","MRNY","PSCH","XLVX","FRTY","TECB","LABU","NVIB","BK4585","MRNX","MEDI","BMED","GDOC","GNMX","IDNA","BBP","IBB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188732548","title":"MEDCAPTAIN's Hong Kong IPO: A Medical Device Empire Built on Acquisitions Faces Multiple Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=1188732548","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188732548?lang=en_us&edition=fundamental","pubTime":"2026-09-11 15:40","pubTimestamp":1789112453,"startTime":"0","endTime":"0","summary":"MEDCAPTAIN has officially launched its global offering on the Hong Kong stock exchange. Originating from a small infusion equipment manufacturer, the company has leveraged capital support and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","IEIH","HART","MEDX","MYLD","BK1583","LNGR","AGNG","BK4585","PTH","02041","LGHT","RSPH","159883","BK1100","MDEV","BK4588","XMMO","09996","GDOC","BK1574","CALF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517941","title":"Nextbiomedical Targets Global Investors at 2026 KIS BioTech Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517941?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:44","pubTimestamp":1789091072,"startTime":"0","endTime":"0","summary":"The latest update is out from Nextbiomedical Co. Ltd. ( ($KR:389650) ). Nextbiomedical Co. Ltd., a biotechnology company, is strengthening its pres...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nextbiomedical-targets-global-investors-at-2026-kis-biotech-day?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nextbiomedical-targets-global-investors-at-2026-kis-biotech-day?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","RSPH","IEIH","JDOC","XT","BBP","ISBC","AGNG","SYNB","IBB","BK4585","DARP","FWD","BK4588","BK4211","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666446516","title":"GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666446516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666446516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:02","pubTimestamp":1789074144,"startTime":"0","endTime":"0","summary":"The latest update is out from GeoVax Labs ( ($GOVX) ). GeoVax Labs, Inc., a clinical-stage biotechnology firm listed on Nasdaq as GOVX, develops va...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","RSPH","BK4097","IEIH","BBP","AGNG","SYNB","DARP","JDOC","BBC","LNGR","LU2065732104.USD","IBB","BK4585","FHLC","FWD","LCLG","BK4588","XT","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143905444","title":"Hongkou Pioneers 'Automatic Benefits' for Veterans' Medical Subsidies, Eliminating Paperwork Trips","url":"https://stock-news.laohu8.com/highlight/detail?id=1143905444","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143905444?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:11","pubTimestamp":1789038664,"startTime":"0","endTime":"0","summary":"Veterans in Hongkou District can now receive medical subsidies without submitting paper invoices or visiting service stations, marking a significant step in streamlining administrative procedures....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","LU0348723411.USD","LU1983260115.SGD","LU1093756325.SGD","SG9999014005.SGD","BK4154","LU0256863811.USD","SG9999014021.USD","LU0170899867.USD","SG9999014013.SGD","LU0417517546.SGD","BK4566","HUM","LU0238689110.USD","BK4588","LU0211331839.USD","LU0208291251.USD","IHF","LU0266013472.USD","BK4585","LU0320765489.SGD","RSPH","BK4533","LU0070302665.USD","FXH","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199145560","title":"Tellgen's Subsidiary Device Registration Application Accepted by Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1199145560","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199145560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:54","pubTimestamp":1789012483,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (SZSE: 300642) has announced that its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently had its medical device registration application accepted for review...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","HART","RSPH","159883","BK1100","LGHT","AGNG","BK0046","PTH","GDOC","BK1583","MDEV","LNGR","300642","09996","BK0042","BK1574","BK0239","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156894230","title":"LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894230","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894230?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:08","pubTimestamp":1788998900,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) has announced that it received an official written notice from the National Medical Products Administration (NMPA) on September 9, 2026, confirming that the LantvalTM aortic...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","MEDX","BK1574","GDOC","MDEV","HART","09996","RSPH","159883","PTH","AGNG","LNGR","IEIH","BK1100","BK1583","BK1600","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530163","title":"Bank of America Reveals 5.22% Indirect Stake in Qiagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530163","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530163?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:37","pubTimestamp":1788986261,"startTime":"0","endTime":"0","summary":"Qiagen ( ($QGEN) ) has issued an update. QIAGEN N.V., a Netherlands-based life sciences and biotechnology group focused on molecular diagnostics an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","LU0648001328.SGD","FWD","IYG","TFNS","LU0130517989.USD","AGNG","IE00B19Z3581.USD","LU1894683264.USD","GNMX","HTEC","LU1718418525.SGD","BBP","FHLC","HELX","KBWB","LU1366192091.USD","LU2129689431.USD","XT","BMED","XLF","RSPH","VFH","LU0070302665.USD","LU0314106906.USD","BK4582","DARP","IE00BKVL7J92.USD","IEIH","LU0208291251.USD","LU0256863902.USD","PGF","LU0321505868.SGD","BK4534","IYF","LU1280957306.USD","FNCL","BK4581","LU1804176565.USD","UYG","BAC","IE00B1BXHZ80.USD","JDOC","LU2133065610.SGD","FTXO","IBB","LU0648000940.SGD","LU1496350502.SGD","LU0256863811.USD","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458412","title":"Revvity to acquire Human Cell Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458412","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458412?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:05","pubTimestamp":1788948328,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) announced it has entered into a definitive agreement to acquire Human Cell Design, or HCD, a France-based biotechnology company spec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN0W2V16.EUR","IEIH","BK4121","IE00BN0W2T93.GBP","RSPH","FHLC","IE00B64QTZ34.USD","SYNB","DARP","FWD","IBB","BK4585","RVTY","IE00BN0W2W23.USD","JDOC","BK4588","BBP","LNGR","IE00BLDYK493.USD","XT","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666301843","title":"Actinogen Medical Expands ASX-Quoted Share Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2666301843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666301843?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:52","pubTimestamp":1788922334,"startTime":"0","endTime":"0","summary":"An announcement from Actinogen Medical ( ($AU:ACW) ) is now available. Actinogen Medical Limited, a biotechnology company listed on the ASX under t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-expands-asx-quoted-share-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-expands-asx-quoted-share-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","BK4588","DARP","FHLC","JDOC","RSPH","SYNB","IBB","BBP","AGNG","XT","LNGR","FWD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}